Basilea Pharmaceutica AG Statistics

Total Valuation

LON:0QNA has a market cap or net worth of GBP 532.94 million. The enterprise value is 524.69 million.

Market Cap	532.94M
Enterprise Value	524.69M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	12.27M
Shares Outstanding	n/a
Shares Change (YoY)	+14.10%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.24M

Valuation Ratios

The trailing PE ratio is 7.79 and the forward PE ratio is 11.79.

PE Ratio	7.79
Forward PE	11.79
PS Ratio	2.90
PB Ratio	7.46
P/TBV Ratio	7.50
P/FCF Ratio	8.32
P/OCF Ratio	8.13
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.83, with an EV/FCF ratio of 8.19.

EV / Earnings	7.67
EV / Sales	2.76
EV / EBITDA	8.83
EV / EBIT	9.32
EV / FCF	8.19

Financial Position

The company has a current ratio of 4.85, with a Debt / Equity ratio of 1.38.

Current Ratio	4.85
Quick Ratio	3.93
Debt / Equity	1.38
Debt / EBITDA	1.71
Debt / FCF	1.54
Interest Coverage	14.20

Financial Efficiency

Return on equity (ROE) is 218.58% and return on invested capital (ROIC) is 24.78%.

Return on Equity (ROE)	218.58%
Return on Assets (ROA)	17.89%
Return on Invested Capital (ROIC)	24.78%
Return on Capital Employed (ROCE)	29.07%
Revenue Per Employee	1.12M
Profits Per Employee	417,048
Employee Count	164
Asset Turnover	0.97
Inventory Turnover	3.99

Taxes

Income Tax	-15.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.38% in the last 52 weeks. The beta is 0.74, so LON:0QNA's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+18.38%
50-Day Moving Average	45.68
200-Day Moving Average	43.97
Relative Strength Index (RSI)	46.90
Average Volume (20 Days)	13,512

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QNA had revenue of GBP 183.82 million and earned 68.40 million in profits. Earnings per share was 5.13.

Revenue	183.82M
Gross Profit	81.73M
Operating Income	54.38M
Pretax Income	53.12M
Net Income	68.40M
EBITDA	55.65M
EBIT	54.38M
Earnings Per Share (EPS)	5.13

Full Income Statement

Balance Sheet

The company has 106.40 million in cash and 98.43 million in debt, giving a net cash position of 7.97 million.

Cash & Cash Equivalents	106.40M
Total Debt	98.43M
Net Cash	7.97M
Net Cash Per Share	n/a
Equity (Book Value)	71.40M
Book Value Per Share	5.89
Working Capital	154.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 65.55 million and capital expenditures -1.51 million, giving a free cash flow of 64.04 million.

Operating Cash Flow	65.55M
Capital Expenditures	-1.51M
Free Cash Flow	64.04M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 44.46%, with operating and profit margins of 29.59% and 37.21%.

Gross Margin	44.46%
Operating Margin	29.59%
Pretax Margin	28.90%
Profit Margin	37.21%
EBITDA Margin	30.27%
EBIT Margin	29.59%
FCF Margin	34.84%

Dividends & Yields

LON:0QNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.10%
Shareholder Yield	n/a
Earnings Yield	12.83%
FCF Yield	12.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0QNA has an Altman Z-Score of -0.94 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.94
Piotroski F-Score	6